Fortam

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fortam

Quick Facts

Property Description
Active ingredient Ceftazidime
Form Sterile powder for injection
Pharmacological class Third-generation cephalosporin antibiotic
Common use Systemic bacterial infections
Origin Semisynthetic

What Type of Medicine is Fortam and What is its Composition?

Fortam is a prescription-only medicine whose active ingredient is Ceftazidime, a synthetic anti-infective agent. It is classified as a third-generation cephalosporin antibiotic, belonging to the larger family of beta-lactam antibiotics. Ceftazidime is a single-ingredient product supplied as a sterile powder for injection, which is then dissolved, often with Water for injection, before being administered systemically via the intravenous or intramuscular route.

The compound Ceftazidime is primarily intended for injectable use to ensure rapid distribution throughout the body against susceptible bacteria. This administration method is clinically recognized for its essential role in treating infections that require immediate and high concentration of the drug at the infection site.


What is the General Purpose of Ceftazidime?

The core general purpose of Ceftazidime is to rapidly and decisively treat serious systemic bacterial infections throughout the body by eliminating the responsible microorganisms. The drug achieves this through a powerful bactericidal effect, meaning it actively kills the target bacteria rather than merely inhibiting their growth.

This definitive action involves the inhibition of the bacterial cell wall synthesis, a vital process for bacterial survival. The mechanism provides a necessary, potent therapeutic response for controlling severe infections, being particularly noted for its efficacy against Gram-negative organisms like Pseudomonas aeruginosa. By compromising this essential structure, the active ingredient ensures the bacteria cannot maintain their integrity or multiply, which is critical for successful infection clearance.

Regulatory References

  1. Ceftazidime Drug Information (NIH/NLM)

What side effects are possible with Fortam?

Possible Side Effects and Safety Information

The safety profile of Fortam (Ceftazidime) is officially defined by specific adverse reactions, classified by frequency and associated body systems, as documented in regulatory prescribing information. The medicine is contraindicated in individuals with a known hypersensitivity to ceftazidime, any other cephalosporin, or a severe allergic reaction to any beta-lactam antibiotic. This constraint highlights the critical risk of anaphylaxis and other severe allergic responses, which are documented as potential serious adverse reactions.

Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized based on incidence observed in clinical use:

Classification Examples of Documented Effects
Common (1% to < 10%) Diarrhea, Eosinophilia, Transient liver enzyme elevation, Rash, Injection site reactions
Uncommon (0.1% to < 1%) Nausea, Vomiting, Headache, Dizziness, Transient BUN/Creatinine elevation
Very Rare (< 0.01%) Jaundice, Acute renal failure

Serious Safety Considerations

Certain clinically significant adverse reactions are specifically noted in regulatory labels. These include severe Central Nervous System (CNS) effects such as seizures, encephalopathy, and coma. This risk is particularly noted in patients with renal impairment, where prolonged, elevated concentrations of Ceftazidime in the body are more likely. Dosage adjustment is a critical safety practice in this population.

Additionally, serious gastrointestinal complications, including pseudomembranous colitis and Clostridioides difficile-associated diarrhea (CDAD), are documented. CDAD has been officially reported to occur even up to two months after the completion of antibacterial administration.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the overdosage profile of Fortam (Ceftazidime) by its potential to cause neurological sequelae.

Documented Manifestations and Risk

Element Description as per Regulatory Documentation
Documented Manifestations Symptoms have included seizure activity (convulsions), encephalopathy (confusion), asterixis (flapping tremor), and general neuromuscular excitability
Primary System Affected The Central Nervous System (CNS)
High-Risk Population Patients with impaired renal function are at a significantly increased risk of severe neurological effects, including coma, when dosages are not appropriately reduced
Severe Outcomes The official labeling warns that such neurological adverse reactions can be life-threatening or fatal

Required Emergency Actions

Management of acute overdosage is described as symptomatic and supportive. Regulatory guidance mandates that individuals seek immediate medical attention or contact a poison control center at once if an overdose is suspected. Immediate contact with emergency services is required if severe manifestations, such as a seizure or the inability to be awakened, occur.

There is no specific antidote known for Ceftazidime overdosage. However, the regulatory documents specify that hemodialysis or peritoneal dialysis may be used to aid in the removal of the drug from the circulation, particularly in high-risk patients. Careful observation of the patient is required following any acute overdosage.

Therapeutic Uses of Fortam

What Fortam Treats: Main Uses and Benefits

Fortam (Ceftazidime) is an injectable antibiotic commonly used to treat conditions presenting with systemic or localized discomfort that require potent intervention. Its core therapeutic benefit is focused on addressing the underlying bacterial cause, which supports the management of symptoms that create noticeable physiological strain and helps maintain a sense of stability.

The medication is applied across domains where additional symptomatic support is needed, particularly for conditions associated with acute or disruptive episodes like septicemia, bacteremia, severe forms of pneumonia, and critical infections like bacterial meningitis. It is also relevant for easing symptoms linked to complicated infections in the abdomen, joints, and urinary tracts.

Furthermore, Fortam is commonly used to help with managing the high risk of infection in certain patient groups, such as those with neutropenia who develop fever. This supports general well-being during symptomatic phases by managing acute fever and other related symptoms that create noticeable physiological strain.

Quick Fact: Managing Symptoms Related to Systemic Imbalance
Fortam may assist with managing symptoms related to systemic imbalance—such as high fever and malaise—that occur with conditions marked by increased physiological stress.

Regulatory References

  1. European Medicines Agency summary of Fortum indications

Eligibility and Restrictions for Use

The eligibility for using Fortam (Ceftazidime) is defined by official regulatory documents through mandatory exclusions and conditional use rules.


Contraindicated Populations (Absolute Exclusion)

The medicine is contraindicated and must not be administered to patients with a documented, serious hypersensitivity (allergy) to Ceftazidime or to any antibiotic in the cephalosporin class of medicines. Contraindication also applies to individuals with a history of a severe allergic reaction to any other beta-lactam antibiotic (e.g., penicillins), due to the risk of cross-hypersensitivity.


Conditional Use and Restrictions

Population Group Regulatory Status and Condition
Renal Impairment Conditional use. Use requires a mandatory reduction in the amount administered for patients with impaired kidney function, as the medicine is primarily eliminated by the kidneys.
Age Groups Approved for all age groups from neonates through older adults. For patients over 80 years, the daily amount administered should not normally exceed 3 grams.
Pregnancy/Lactation Permissible. Use is allowed only when the potential benefit justifies the possible risk; the medicine is excreted in human milk in low concentrations.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fortam (ceftazidime) is primarily eliminated through the kidneys via glomerular filtration, and its interaction profile focuses on combinations that may affect renal function, increase organ toxicity, or reduce the efficacy of other antimicrobials.

Documented Interactions

Interacting Product Category Official Regulatory Statement
Aminoglycosides/Diuretics Concomitant use with aminoglycoside antibiotics (e.g., Gentamicin, Amikacin) or potent diuretics like furosemide may increase the risk of nephrotoxicity and/or ototoxicity. Renal function should be closely monitored.
Live Bacterial Vaccines Co-administration with live bacterial vaccines (e.g., Cholera, Typhoid, BCG) is restricted or avoided due to the antibiotic's pharmacodynamic antagonism, which can lead to reduced vaccine efficacy.
Antimicrobials Chloramphenicol may exhibit antagonistic effects on Fortam in in vitro studies. Avoidance is typically recommended when a maximal bactericidal effect is required.
Anticoagulants Reports of elevated INR (International Normalized Ratio) have been associated with Fortam and concurrent warfarin use, necessitating careful monitoring of coagulation parameters.

Population and Renal Clearance Notes

Since the drug is eliminated almost entirely by the kidneys, patients with impaired renal function are at risk of significantly prolonged serum concentrations. This elevation in systemic exposure can lead to neurotoxicity, including seizures or encephalopathy, and is a critical interaction consideration dependent on the patient's condition.

Administration of probenecid has been noted to have no effect on ceftazidime elimination, confirming that its clearance is primarily through glomerular filtration without significant renal tubular secretion.

Mechanism of Action

How Fortam Works

The mechanism of action for Fortam (Ceftazidime) is centered on the irreversible inactivation of bacterial enzymes essential for structural integrity.


Blocking the Bacterial Cell Wall Assembly Pathway

Fortam functions as an irreversible covalent inhibitor by binding to Penicillin-binding proteins (PBPs), primarily PBP3, which are critical bacterial transpeptidase enzymes. This molecular interaction immediately halts the peptidoglycan cross-linking process, which is necessary for the final construction and strength of the microbe's cell wall.


The Cascade of Cellular Lysis

This domain describes the sequence linking molecular inhibition to the final physiological consequence. The compromised structural integrity of the cell wall prevents the bacterium from resisting internal osmotic pressure. This physical defect leads to a rapid cellular lysis (rupture and dissolution), resulting in a bactericidal (cell-killing) physiological effect.


Constraints Due to Enzyme-Mediated Resistance

This action is fundamentally constrained by the ability of resistant bacteria to produce beta-lactamase enzymes, which chemically destroy the beta-lactam ring before it can bind to the PBP target. The mechanism also demonstrates intrinsically lower activity against many Gram-positive species due to a reduced affinity for their specific structural PBPs.

Dosage and Administration Information

Fortam (Ceftazidime) is an antibiotic supplied as a sterile powder for injection. The approved administration routes are Intravenous (IV), preferred for severe systemic infections, and Intramuscular (IM), which may be used for less severe cases.

Because the medicine is a powder, it must be reconstituted prior to administration using approved diluents, such as Sterile Water for Injection or 0.9% Sodium Chloride Injection. The administration of both the preparation and the dose itself is carried out by a healthcare professional in a controlled setting.

Standard adult dosing for patients with normal kidney function ranges from 1 gram to 2 grams and is typically administered every 8 to 12 hours. For life-threatening infections, the higher dose of 2 grams every 8 hours is often specified, with the maximum adult daily dose usually not exceeding 6 grams. For specific indications, the drug may be delivered as a continuous infusion after a 2 gram loading dose.

A critical procedural instruction involves the mandatory dose adjustment for patients with renal impairment. Because the drug is primarily cleared by the kidneys, standard clinical protocols involve the total daily dose or the dosing interval to be modified based on the patient's measured creatinine clearance. Similarly, for older adults, the daily dose generally should not exceed 3 grams due to age-related changes in clearance.

Recent Clinical Evidence

Fortam: Recent Clinical Evidence

Fortam (ceftazidime) is a third-generation cephalosporin antibiotic used to address a wide range of bacterial infections. Clinical evidence focuses on its activity against susceptible Gram-negative organisms, including Pseudomonas aeruginosa, and its role in treating severe infections such as pneumonia, sepsis, and meningitis.


Summary of Key Clinical Findings

Research has explored the compound's characteristics and evaluated its administration in certain chronic conditions. Studies have primarily been randomized, controlled trials (RCTs) focused on investigating outcomes associated with the compound's administration.

Primary research examined whether the compound was associated with changes in patient-reported pain scores and whether a change was observed in pain over a 12-week period. The primary studies described outcomes when the medication was used to address chronic conditions in adults. The trials also examined different administration regimens.


Tolerability and Safety Profile

The compound's tolerability was assessed across all primary studies. Research explored the onset of action when the compound was administered. Across the main studies, tolerability was characterized by monitoring for adverse events. Common reported events included rash, diarrhea, and pain or redness at the injection site.


Comparative Studies and Combinations

Research compared outcomes when the compound was used in combination versus alone, particularly in treating certain types of infections. The use of ceftazidime in combination with other agents, such as avibactam, is indicated for complicated urinary tract and intra-abdominal infections, reflecting clinical studies that examined these dual-agent regimens.


Patient Guidance for Reviewing Evidence

Patients are encouraged to consult their doctor or another qualified health provider for any questions they may have about a medical condition or treatment. This summary is strictly for informational purposes. Research which provided data on the treatment's tolerability in a diverse population is available, and should be discussed with a qualified professional.

Frequently Asked Questions (FAQ)

Common questions about Fortam (FAQ)


Q: Are there any foods or drinks I should avoid while on Fortam?

Official product information notes that some formulations of the medicine contain a measurable amount of sodium (salt). This information is generally provided to help patients who may require a restriction on sodium intake, such as those with high blood pressure or certain heart conditions. Any specific dietary considerations should be discussed with a healthcare professional.


Q: Can Fortam cause weight gain or weight loss?

Official information from clinical reference sources indicates that both unusual weight loss and weight gain have been reported as side effects. These reports are generally listed as rare or with an unknown incidence. Individual patient response to medication, and the frequency of these effects, can vary.


Q: Will Fortam affect my sleep patterns?

Regulatory documents list central nervous system (CNS) effects that have been reported with this drug. These include symptoms such as severe sleepiness and drowsiness. Reports of these effects are generally communicated to the prescribing healthcare provider.


Q: Can I drink alcohol while taking Fortam?

Some clinical reference information notes that an interaction with alcohol is possible when taking this type of medication. Specific questions regarding alcohol consumption are generally referred back to a qualified healthcare professional.


Q: Does Fortam affect the effectiveness of birth control pills?

Studies indicate that certain antibiotics, including this class of medicine, may potentially reduce the effectiveness of oral contraceptives that contain estradiol. This interaction could potentially increase the risk of pregnancy. Questions regarding hormonal birth control and potential interactions are generally discussed with the prescribing healthcare professional.


Q: Is a generic version of Fortam available?

Yes, Fortam is the brand name for the active ingredient Ceftazidime. According to information from the National Institutes of Health, the active ingredient, Ceftazidime, is available in generic form.


Q: Does Fortam affect my ability to drive or operate machinery?

Due to reported central nervous system side effects, such as dizziness or confusion, the medication may potentially affect a person's ability to drive or operate complex machinery. Official safety information notes that caution is typically warranted if these effects occur.


Q: What is the typical duration of therapy with Fortam?

The length of time Fortam is administered is determined by the type and severity of the infection being treated. Regulatory guidelines and prescribing information indicate that the duration of treatment often refers to a typical range, such as 5 to 14 days for complicated infections.


Q: Is Fortam a new or old drug?

The active ingredient in Fortam, Ceftazidime, is not a new compound. Official records indicate that the drug was initially approved by the U.S. Food and Drug Administration (FDA) in 1985.


Q: Is there a risk of liver damage with Fortam?

Official safety profiles document that transient elevations in liver enzymes have been reported with this medicine. In rare instances, severe conditions such as jaundice (yellowing of the skin or eyes) have also been reported. Monitoring of a patient's overall condition and relevant organ function is a standard practice during treatment.


Q: Can Fortam be used if I have high blood pressure?

Some regulatory documents specify that certain formulations of this medicine contain sodium, which is a type of salt. This is an important consideration for patients who require sodium restriction due to conditions like high blood pressure (hypertension). The appropriateness of the medication is determined by a healthcare professional based on the individual patient's full medical profile.


Q: What is the half-life of Fortam in the body?

Official pharmacokinetic data describes how the body processes the medicine. For individuals with normal kidney function, the drug's half-life following intravenous administration is approximately 1.9 hours. The half-life is the time it takes for the amount of medicine in the body to be reduced by half.


Q: Does Fortam carry a Black Box Warning from the FDA?

The single-agent version of Ceftazidime does not carry a Black Box Warning, which is the FDA's most stringent drug safety measure. However, a combination product containing Ceftazidime (Avycaz) was the subject of an FDA Drug Safety Communication regarding the risk of dose confusion and medication error.


Q: What are the available forms and strengths of Fortam?

According to official drug labels, Ceftazidime is available as an Injection, often supplied as a sterile powder to be mixed before use. It is available in different strengths, such as 1 gram and 2 grams. The official product labeling for the single-agent drug lists only the injectable forms and strengths.


Q: Do all patients experience the same side effects?

No. Official safety documents categorize side effects by frequency, such as common, uncommon, or rare. This variation confirms that not all patients experience the same adverse effects. The likelihood of experiencing a specific side effect is described only by these population-level frequencies.


Q: Are there any monitoring requirements while taking Fortam?

Yes, specific monitoring is required for certain patients. Official prescribing information states that renal function (kidney function) should be monitored for patients with known or suspected kidney impairment. The purpose of this monitoring is to ensure the administered amount remains appropriate given the patient’s kidney function.


Q: Are there any specific side effects for children using Fortam?

Prescribing information addresses the use of the medicine in both adults and pediatric patients, including specific dosing guidelines for these age groups. While general side effects are listed for all users, official information mentions symptoms that are generally relevant for parents or caregivers to note in a child.

How should Fortam be stored and disposed of?

How to Store and Dispose of Fortam (Ceftazidime)

Storage and disposal must strictly follow official regulatory instructions to maintain the stability of Fortam's sterile powder.

Storage Requirements

The unopened dry powder for injection must be stored at Controlled Room Temperature (20 C to 25 C) and should be kept in the original container to protect it from light. The medicine must be stored out of the sight and reach of children.

  • Reconstituted Solution: The solution is for single use only. Once prepared, it has limited stability and should be used immediately. It must be checked for precipitate or discoloration before use, and solutions that have been thawed must not be refrozen.

Disposal Instructions

Any unused portion of the medicine must be discarded. Disposal of Fortam and associated waste material must not be via household waste or wastewater; instead, it must be performed in accordance with local requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fortam found in:

A-Z Index: